Wedbush Upgrades Staar Surgical to Outperform, Raises Price Target to $40

Benzinga Newsdesk www.benzinga.com Positive 92.2%

Neg 0% Neu 0% Pos 92.2%

Wedbush analyst Michael Piccolo upgrades Staar Surgical (NASDAQ:STAA) from Neutral to Outperform and raises the price target from $26 to $40.